Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi. / Peña-Espinoza, Miguel; Romero-Uzqueda, Yeambell; Valente, Angela H.; de Roode, Matthew; Simonsen, Henrik T.; Thamsborg, Stig M.; Williams, Andrew R.; López-Muñoz, Rodrigo.

In: International Journal for Parasitology: Drugs and Drug Resistance, Vol. 20, 2022, p. 43-53.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Peña-Espinoza, M, Romero-Uzqueda, Y, Valente, AH, de Roode, M, Simonsen, HT, Thamsborg, SM, Williams, AR & López-Muñoz, R 2022, 'Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi', International Journal for Parasitology: Drugs and Drug Resistance, vol. 20, pp. 43-53. https://doi.org/10.1016/j.ijpddr.2022.08.002

APA

Peña-Espinoza, M., Romero-Uzqueda, Y., Valente, A. H., de Roode, M., Simonsen, H. T., Thamsborg, S. M., Williams, A. R., & López-Muñoz, R. (2022). Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi. International Journal for Parasitology: Drugs and Drug Resistance, 20, 43-53. https://doi.org/10.1016/j.ijpddr.2022.08.002

Vancouver

Peña-Espinoza M, Romero-Uzqueda Y, Valente AH, de Roode M, Simonsen HT, Thamsborg SM et al. Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi. International Journal for Parasitology: Drugs and Drug Resistance. 2022;20:43-53. https://doi.org/10.1016/j.ijpddr.2022.08.002

Author

Peña-Espinoza, Miguel ; Romero-Uzqueda, Yeambell ; Valente, Angela H. ; de Roode, Matthew ; Simonsen, Henrik T. ; Thamsborg, Stig M. ; Williams, Andrew R. ; López-Muñoz, Rodrigo. / Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi. In: International Journal for Parasitology: Drugs and Drug Resistance. 2022 ; Vol. 20. pp. 43-53.

Bibtex

@article{18e8d7c0750e4671a76203d5eb282e2d,
title = "Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi",
abstract = "Chagas disease, caused by the protozoa Trypanosoma cruzi, is a potentially life-threatening parasitic zoonosis infecting 6–7 million people worldwide, mainly in Latin America. Due to the limited numbers of drugs available against this neglected disease and their frequent adverse effects, novel anti-chagasic agents are urgently needed. Cichorium intybus L. (chicory) is a bioactive plant with potent activity against parasitic nematodes, but its effects on protozoans are poorly known and no studies have explored its trypanocidal potential. Here, we investigated the activity of C. intybus against extracellular and intracellular stages of T. cruzi, including the prediction of trypanocidal compounds by metabolomic analyses and bioactivity-based molecular networking. Purified C. intybus extracts were prepared from leaves and roots of five C. intybus cultivars (cv. {\textquoteleft}Benulite{\textquoteright}, {\textquoteleft}Goldine{\textquoteright}, {\textquoteleft}Larigot{\textquoteright}, {\textquoteleft}Maestoso{\textquoteright} and {\textquoteleft}Spadona{\textquoteright}). All C. intybus extracts induced concentration-dependent effects against T. cruzi trypomastigotes. C. intybus leaf extracts had higher trypanocidal selectivity and lower cytotoxicity on mammalian cells than root extracts. The leaf extract of C. intybus cv. Goldine also significantly reduced the number of mammalian cells infected with T. cruzi amastigotes. Metabolomic and bioactivity-based molecular networking analyses revealed 11 compounds in C. intybus leaves strongly linked with activity against trypomastigotes, including the sesquiterpene lactone lactucin, and flavonoid- and fatty acid-derivatives. Furthermore, seven distinct C. intybus molecules (including two sesquiterpene lactone-derivatives) were predicted to be involved in reducing the number of mammalian cells infected with amastigotes. This is the first report of the anti-protozoal activity of C. intybus against trypanosomatid parasites and expands our understanding of the anti-parasitic effects of this plant and its bioactive metabolites. Further studies to elucidate the anti-protozoal compound(s) in C. intybus and their mode(s) of action will improve our knowledge of using this bioactive plant as a promising source of novel broad-spectrum anti-parasitic compounds with associated health benefits and biomedical potential.",
keywords = "Anti-protozoal, Chagas disease, Cichorium intybus, Metabolomics, Sesquiterpene lactones, Trypanosoma cruzi",
author = "Miguel Pe{\~n}a-Espinoza and Yeambell Romero-Uzqueda and Valente, {Angela H.} and {de Roode}, Matthew and Simonsen, {Henrik T.} and Thamsborg, {Stig M.} and Williams, {Andrew R.} and Rodrigo L{\'o}pez-Mu{\~n}oz",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
doi = "10.1016/j.ijpddr.2022.08.002",
language = "English",
volume = "20",
pages = "43--53",
journal = "International Journal for Parasitology",
issn = "0020-7519",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Anti-protozoal activity and metabolomic analyses of Cichorium intybus L. against Trypanosoma cruzi

AU - Peña-Espinoza, Miguel

AU - Romero-Uzqueda, Yeambell

AU - Valente, Angela H.

AU - de Roode, Matthew

AU - Simonsen, Henrik T.

AU - Thamsborg, Stig M.

AU - Williams, Andrew R.

AU - López-Muñoz, Rodrigo

N1 - Publisher Copyright: © 2022 The Authors

PY - 2022

Y1 - 2022

N2 - Chagas disease, caused by the protozoa Trypanosoma cruzi, is a potentially life-threatening parasitic zoonosis infecting 6–7 million people worldwide, mainly in Latin America. Due to the limited numbers of drugs available against this neglected disease and their frequent adverse effects, novel anti-chagasic agents are urgently needed. Cichorium intybus L. (chicory) is a bioactive plant with potent activity against parasitic nematodes, but its effects on protozoans are poorly known and no studies have explored its trypanocidal potential. Here, we investigated the activity of C. intybus against extracellular and intracellular stages of T. cruzi, including the prediction of trypanocidal compounds by metabolomic analyses and bioactivity-based molecular networking. Purified C. intybus extracts were prepared from leaves and roots of five C. intybus cultivars (cv. ‘Benulite’, ‘Goldine’, ‘Larigot’, ‘Maestoso’ and ‘Spadona’). All C. intybus extracts induced concentration-dependent effects against T. cruzi trypomastigotes. C. intybus leaf extracts had higher trypanocidal selectivity and lower cytotoxicity on mammalian cells than root extracts. The leaf extract of C. intybus cv. Goldine also significantly reduced the number of mammalian cells infected with T. cruzi amastigotes. Metabolomic and bioactivity-based molecular networking analyses revealed 11 compounds in C. intybus leaves strongly linked with activity against trypomastigotes, including the sesquiterpene lactone lactucin, and flavonoid- and fatty acid-derivatives. Furthermore, seven distinct C. intybus molecules (including two sesquiterpene lactone-derivatives) were predicted to be involved in reducing the number of mammalian cells infected with amastigotes. This is the first report of the anti-protozoal activity of C. intybus against trypanosomatid parasites and expands our understanding of the anti-parasitic effects of this plant and its bioactive metabolites. Further studies to elucidate the anti-protozoal compound(s) in C. intybus and their mode(s) of action will improve our knowledge of using this bioactive plant as a promising source of novel broad-spectrum anti-parasitic compounds with associated health benefits and biomedical potential.

AB - Chagas disease, caused by the protozoa Trypanosoma cruzi, is a potentially life-threatening parasitic zoonosis infecting 6–7 million people worldwide, mainly in Latin America. Due to the limited numbers of drugs available against this neglected disease and their frequent adverse effects, novel anti-chagasic agents are urgently needed. Cichorium intybus L. (chicory) is a bioactive plant with potent activity against parasitic nematodes, but its effects on protozoans are poorly known and no studies have explored its trypanocidal potential. Here, we investigated the activity of C. intybus against extracellular and intracellular stages of T. cruzi, including the prediction of trypanocidal compounds by metabolomic analyses and bioactivity-based molecular networking. Purified C. intybus extracts were prepared from leaves and roots of five C. intybus cultivars (cv. ‘Benulite’, ‘Goldine’, ‘Larigot’, ‘Maestoso’ and ‘Spadona’). All C. intybus extracts induced concentration-dependent effects against T. cruzi trypomastigotes. C. intybus leaf extracts had higher trypanocidal selectivity and lower cytotoxicity on mammalian cells than root extracts. The leaf extract of C. intybus cv. Goldine also significantly reduced the number of mammalian cells infected with T. cruzi amastigotes. Metabolomic and bioactivity-based molecular networking analyses revealed 11 compounds in C. intybus leaves strongly linked with activity against trypomastigotes, including the sesquiterpene lactone lactucin, and flavonoid- and fatty acid-derivatives. Furthermore, seven distinct C. intybus molecules (including two sesquiterpene lactone-derivatives) were predicted to be involved in reducing the number of mammalian cells infected with amastigotes. This is the first report of the anti-protozoal activity of C. intybus against trypanosomatid parasites and expands our understanding of the anti-parasitic effects of this plant and its bioactive metabolites. Further studies to elucidate the anti-protozoal compound(s) in C. intybus and their mode(s) of action will improve our knowledge of using this bioactive plant as a promising source of novel broad-spectrum anti-parasitic compounds with associated health benefits and biomedical potential.

KW - Anti-protozoal

KW - Chagas disease

KW - Cichorium intybus

KW - Metabolomics

KW - Sesquiterpene lactones

KW - Trypanosoma cruzi

U2 - 10.1016/j.ijpddr.2022.08.002

DO - 10.1016/j.ijpddr.2022.08.002

M3 - Journal article

C2 - 36037562

AN - SCOPUS:85136598910

VL - 20

SP - 43

EP - 53

JO - International Journal for Parasitology

JF - International Journal for Parasitology

SN - 0020-7519

ER -

ID: 319162876